Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-03

Clinical Trial Update: MCS in the Treatment of Lower Urinary Tract Symptoms [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on MCS for lower urinary tract symptoms including benign prostatic hyperplasia, conducted in Phase 2 and Phase 3, with the trial status sh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MCS®

Snippet

Sponsor: Health Ever Bio-Tech Co., Ltd. | Conditions: Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia | Phase 2, Phase 3 | Status: COMPLETED